Helios Healthcare USA, Inc.
Corporation · Dover, United States · LEI 529900TFNV564JQA4Y79
LEI lapsed
Summary
Helios Healthcare USA, Inc. is registered in the United States. Its legal form is Corporation. According to GLEIF, its ultimate parent is Fresenius SE & Co. KGaA (Germany), which is also its direct parent. That group has 95 subsidiaries with LEIs in 42 countries, 8 of them in the United States. The LEI was first issued on 25 Feb 2021 and the record was last updated on 25 Feb 2025. It has lapsed: renewal was due by 25 Feb 2025. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 25 Feb 2025 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2022, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 25 Feb 2025.
Company details
| Legal form | Corporation |
|---|---|
| Register | · Register website |
| Registration number | 4236921 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | c/o COGENCY GLOBAL INC., 850 New Burton Road, Suite 201,, 19904 Dover, United States |
| Headquarters address | c/o COGENCY GLOBAL INC., 850 New Burton Road, Suite 201, 19904 Dover, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 2 Dec 2020 |
| LEI | 529900TFNV564JQA4Y79 |
| LEI status | lapsed |
| LEI first issued | 25 Feb 2021 |
| LEI record last updated | 25 Feb 2025 |
| Next LEI renewal | 25 Feb 2025 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Helios Healthcare USA, Inc. this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | Fresenius SE & Co. KGaA | Fresenius SE & Co. KGaA |
| Accounting period | 1 Jan 2022 to 31 Dec 2022 | 1 Jan 2022 to 31 Dec 2022 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | fully corroborated | fully corroborated |
| Relationship start | 25 Feb 2021 | 25 Feb 2021 |
| Recorded at GLEIF since | 25 Feb 2021 | 25 Feb 2021 |
| Last updated | 25 Feb 2025 | 25 Feb 2025 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (92)
- Fenwal, Inc. United States
- Fresenius Kabi Compounding, LLC United States lapsed
- Fresenius Kabi Holding, Inc. United States lapsed
- FRESENIUS KABI PHARMACEUTICALS HOLDING, LLC United States
- Fresenius Kabi USA, LLC United States
- Fresenius Kabi, LLC United States
- "FRESENIUS KABI POLSKA" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Poland
- AUDERE MEDICAL SERVICES LIMITED United Kingdom
- AVENSYS UK GROUP LIMITED United Kingdom
- AVENSYS UK LTD United Kingdom
- AVENSYS UK TRAINING LIMITED United Kingdom
- Calea Ltd. Canada